美国惩教公司 CXW 深 沪
等待开盘 12-18 09:30:00 美东时间
19.47
+0.450
+2.37%
华盛通- 最 高19.545
- 今 开18.93
- 成交量 89.88万股
- 最 低 18.90
- 昨 收 19.02
- 总市值 20.83亿
- 52周最高 23.85
- 市盈率 静 31.36
- 换手率 0.84%
- 52周最低 15.95
- 委 比 -58.42%
- 总股本 1.07亿
- 历史最高 32.51
- 量 比 0.90
- 振 幅 3.39%
- 历史最低 5.76
- 每 手 1
- 风险率 1.59%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CoreCivic Announces Promotion of Daren Swenson to Executive Vice President And Chief Corrections and Reentry Officer
CoreCivic announced that Daren Swenson, currently Senior Vice President and Chief Corrections Officer, has been appointed as Executive Vice President and Chief Corrections and Reentry Officer (CCRO), effective January 1, 2026. Swenson will oversee corrections, detention, and reentry facilities. CEO Damon Hininger praised Swenson's leadership and expertise, while COO Patrick Swindle highlighted his experience and contributions to operational excel...
12-12 13:00
Oracle Q2 FY2026 Earnings Call Transcript
Here is the transcript of Oracle's Q2 FY2026 earnings call.
12-11 07:44
Palantir, others may have 'improper ties' to Trump administration: Dem. lawmakers
Palantir Technologies (PLTR) and several other companies — including privately held defense contractor Anduril — may be benefiting due to alleged “improper ties” to the Trump administration, a group o...
12-10 04:51
CoreCivic Announces Expansion of Revolving Credit Facility By $300 Million
CoreCivic announced it has expanded its credit facilities by increasing the accordion feature from $200 million to $300 million and raising the Revolving Credit Facility capacity to $575 million, providing additional borrowing flexibility for future growth and strategic investments. The company has $165 million in outstanding borrowings and $391.4 million in additional capacity. CoreCivic expects significant revenue and cash flow growth in 2026 a...
12-02 13:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
CoreCivic Announces $200 Million Increase to Share Repurchase Authorization
CoreCivic announced an increase to its share repurchase program, raising the authorization from $500 million to $700 million. Since the program's inception in May 2022, CoreCivic has repurchased 21.5 million shares at a total cost of $322.1 million. Approximately $377.9 million remains available under the program. CEO Damon T. Hininger expressed enthusiasm for the increased authorization, noting the company's commitment to enhancing shareholder v...
11-10 13:00
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
Jones Trading Maintains Buy on CoreCivic, Maintains $30 Price Target
Jones Trading analyst Jason Weaver maintains CoreCivic (NYSE:CXW) with a Buy and maintains $30 price target.
11-08 06:59
CoreCivic shares are trading lower after lowering FY2025 FFO guidance.
CoreCivic shares are trading lower after lowering FY2025 FFO guidance.
11-06 23:17
Earnings Scheduled For November 5, 2025
Companies Reporting Before The Bell • Avient (NYSE:AVNT) is estimated to report...
11-05 19:12
